Two Centuries of Assessing Drug Risks

被引：26

作者：

Avorn, Jerry ^{[1
,2
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA 02115 USA

[2] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA

来源：

关键词：

LITIGATION;

D O I：

10.1056/NEJMp1206652

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：193 / 197

页数：5

共 5 条

Graham, David Y. ;

Jewell, Nicholas P. ;

Chan, Francis K. L. .

[2]

Harris G., 2006, NY TIMES

[3]

Holmes OW, 1919, BARTLETTS FAMILIAR Q

[4] The role of litigation in defining drug risks [J].

Kesselheim, Aaron S. ;

Avorn, Jerry .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (03) :308-311

Madigan, David ;

Sigelman, Daniel W. ;

Mayer, James W. ;

Furberg, Curt D. ;

Avorn, Jerry .